Racial/Ethnic Differences in Comprehension of Biospecimen Collection: a Nationwide University of Rochester Cancer Center NCI Community Oncology Research Program Study
Matthew Asare(Baylor University), Michelle C. Janelsins(University of Rochester), Lori M. Minasian(National Cancer Institute), Charles Kamen(University of Rochester), Michelle Feige(AARP), Carol J. Weil(National Cancer Institute), Charles E. Heckler(University of Rochester Medicine), Gary R. Morrow(University of Rochester Medical Center), Sharon Cole(Dayton Clinical Oncology Program), David Wendler(National Institutes of Health Clinical Center), Eva Culakova(University of Rochester), Adedayo A. Onitilo(Marshfield Clinic Weston Center), Amber S. Kleckner(University of Maryland, Baltimore), Joan Long(Michigan Cancer Research Consortium), Luke J. Peppone(University of Rochester Medical Center)
Cited by 4
Related Papers
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JNCI Journal of the National Cancer Institute|2014|1.1k
Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
|JAMA Oncology|2015|1k
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
|Journal of Clinical Oncology|1999|670